SLU-PP-332 – 250mcg Capsules (50 Count Bottle)

SLU-PP-332 – 250 mcg Capsules (50 Count Bottle)

Full Product Description:

SLU-PP-332 (CAS 303760-60-3) is a research-grade synthetic small molecule serving as a potent pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ), with highest affinity for ERRα (EC₅₀ ≈ 98 nM in cell-based assays). This compound activates ERR-mediated transcriptional programs that mimic aspects of acute aerobic exercise responses, making it a valuable tool for laboratory investigations into mitochondrial biogenesis, cellular respiration, fatty acid oxidation, and energy expenditure pathways in in vitro and preclinical models.

In published mechanistic studies, SLU-PP-332 has been utilized to explore ERR-dependent effects on mitochondrial function, skeletal muscle fiber type shifts (e.g., increased type IIa oxidative fibers), metabolic flux in adipocytes and hepatocytes, and whole-body energy homeostasis in controlled experimental systems. It provides a unique platform for researchers to dissect the roles of ERR isoforms in nuclear receptor signaling, PGC-1α coactivation, and related metabolic cascades—distinct from traditional exercise or AMPK-focused interventions.

Each capsule contains 250 mcg of SLU-PP-332 as a dry powder fill (with inert excipients for stability and handling), supplied in a 100-count bottle for extended experimental protocols, dose-response titrations, or multi-replicate studies. The compound is ≥98% pure by HPLC, with third-party verification including mass spectrometry and analytical certificates available upon request. Capsules are provided exclusively as inert containers for research material transport, storage, and precise aliquoting in lab settings—not as dosage forms.

Specifications

• Quantity per Capsule: 250 mcg SLU-PP-332
• Bottle Count: 100 capsules
• Form: Dry powder-filled gelatin capsules (research-grade, non-pharmaceutical)
• Molecular Formula: C₁₈H₁₄N₂O₂
• Molecular Weight: 290.32 g/mol
• CAS No.: 303760-60-3
• Chemical Name: (E)-4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide
• Purity: ≥98% (HPLC verified, third-party tested)
• Storage: Keep sealed at -20°C (dry); protect from light and moisture. Stable for 24+ months lyophilized/dry.

Intended Use Strictly for in vitro laboratory research and preclinical studies by qualified professionals in controlled scientific environments. Not for human or animal consumption, ingestion, therapeutic, diagnostic, veterinary, food, cosmetic, or any non-research applications. Capsules must not be opened, administered, or used outside qualified lab protocols. All handling requires adherence to institutional biosafety, sterile technique, and regulatory guidelines.

FDA Disclaimer The information on this website has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). No statements herein, nor any products offered, are intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Alamo Peptides supplies research reagents exclusively—we are not a compounding pharmacy, do not operate under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, are not a pharmaceutical company, and do not conduct or support clinical trials. By purchasing, you confirm qualification as a researcher and assume full responsibility for lawful handling, use, and compliance.

Terms of Sale All sales final due to research material sensitivity. Buyers must be 21+ and may be required to verify credentials. Misuse voids any warranties; Alamo Peptides assumes no liability for improper application.

For COAs, batch details, or inquiries: Contact support@alamopeptides.com or via Discord/Telegram.